Therapeutic Approaches to Target Inflammation in Type 2 Diabetes
- 1 February 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 57 (2) , 162-167
Abstract
BACKGROUND: Chronic inflammation may participate in the pathogenesis of insulin resistance, type 2 diabetes, and cardiovascular disease and may be a common denominator that links obesity to these disease states. CONTENT: Epidemiologic studies have linked inflammatory biomarkers to incident diabetes and cardiovascular disease risk. Cellular and animal studies have provided support to the idea that inflammation mediates these disease processes, providing impetus to pharmacologically target these pathways for disease treatment and prevention. We review clinical strategies to target inflammation, with a focus on the antiinflammatory and antihyperglycemic effects of salicylates. SUMMARY: The evolving concept of diet-induced obesity driving insulin resistance, type 2 diabetes, and cardiovascular disease through immunologic processes provides new opportunities for the use of antiinflammatory strategies to correct the metabolic consequences of excess adiposity.Keywords
Funding Information
- NIH (U01DK074556, R01HL091750, P50HL083813, P30DK036836, U01DK074556, R01HL091750, U01DK074556, R01HL091750, P50HL083813, P30DK036836)
This publication has 48 references indexed in Scilit:
- TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2011
- Thirty-One Novel Biomarkers as Predictors for Clinically Incident DiabetesPLOS ONE, 2010
- Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight GainDiabetes Care, 2009
- Nuclear Factor-κB Activation Contributes to Vascular Endothelial Dysfunction via Oxidative Stress in Overweight/Obese Middle-Aged and Older HumansCirculation, 2009
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive ProteinNew England Journal of Medicine, 2008
- Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 DiabetesClinical and Translational Science, 2008
- Salsalate Improves Glycemia and Inflammatory Parameters in Obese Young AdultsDiabetes Care, 2008
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Effects of Etanercept in Patients With the Metabolic SyndromeArchives of internal medicine (1960), 2006
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005